Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

VALERIO, Maria Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.274
EU - Europa 5.860
AS - Asia 5.192
SA - Sud America 864
AF - Africa 122
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.322
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.080
SG - Singapore 1.988
RU - Federazione Russa 1.543
CN - Cina 1.273
IT - Italia 1.048
DE - Germania 781
BR - Brasile 679
FI - Finlandia 609
VN - Vietnam 535
HK - Hong Kong 534
UA - Ucraina 426
PL - Polonia 331
GB - Regno Unito 278
FR - Francia 226
IE - Irlanda 188
JP - Giappone 183
SE - Svezia 140
IN - India 125
BD - Bangladesh 116
KR - Corea 100
CA - Canada 97
AR - Argentina 83
MX - Messico 54
IQ - Iraq 53
NL - Olanda 51
TR - Turchia 50
BE - Belgio 45
AT - Austria 42
ES - Italia 37
UZ - Uzbekistan 29
RO - Romania 26
ZA - Sudafrica 25
PK - Pakistan 24
AE - Emirati Arabi Uniti 22
EC - Ecuador 22
IR - Iran 22
CO - Colombia 18
VE - Venezuela 18
GR - Grecia 17
ID - Indonesia 17
KE - Kenya 15
MA - Marocco 15
TN - Tunisia 15
CI - Costa d'Avorio 14
DZ - Algeria 13
PY - Paraguay 13
MY - Malesia 12
PH - Filippine 12
SA - Arabia Saudita 12
CH - Svizzera 11
CZ - Repubblica Ceca 11
NP - Nepal 11
CL - Cile 10
EG - Egitto 10
JM - Giamaica 10
HN - Honduras 9
KZ - Kazakistan 9
AL - Albania 8
LT - Lituania 8
PE - Perù 8
GE - Georgia 7
LB - Libano 7
RS - Serbia 7
UY - Uruguay 7
IL - Israele 6
JO - Giordania 6
BG - Bulgaria 5
PA - Panama 5
TH - Thailandia 5
AU - Australia 4
AZ - Azerbaigian 4
BH - Bahrain 4
BO - Bolivia 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
EU - Europa 4
NO - Norvegia 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
CR - Costa Rica 3
NG - Nigeria 3
OM - Oman 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BZ - Belize 2
DK - Danimarca 2
EE - Estonia 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MN - Mongolia 2
PR - Porto Rico 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CM - Camerun 1
CY - Cipro 1
Totale 21.298
Salva come PNG Salva come JPEG
Città #
Singapore 1.352
Ashburn 1.118
Fairfield 860
San Jose 611
Chandler 538
Hong Kong 514
Woodbridge 488
Wilmington 444
Houston 366
Ann Arbor 360
Seattle 341
Moscow 306
Zgierz 293
Cambridge 281
Jacksonville 231
Beijing 204
Dublin 189
Santa Clara 181
Ho Chi Minh City 175
Tokyo 172
Medford 169
Council Bluffs 145
Los Angeles 144
New York 142
Des Moines 140
Hefei 138
Hanoi 135
Palermo 132
Lauterbourg 131
Dallas 126
Frankfurt am Main 124
Princeton 107
Altamura 104
Nanjing 99
The Dalles 95
Lawrence 79
Milan 75
Boardman 74
São Paulo 72
Helsinki 71
Buffalo 70
Chicago 64
San Diego 60
Rome 58
Tulsa 58
Dearborn 55
Ludwigshafen am Rhein 53
London 47
Brussels 45
Nuremberg 41
Shenyang 39
Tianjin 38
Orem 37
Jinan 36
Hebei 35
Venice 35
Seongnam 33
Montreal 32
Munich 32
Seoul 30
Da Nang 29
Nanchang 27
Falls Church 26
Lappeenranta 26
Rio de Janeiro 26
Columbus 25
Stockholm 24
Warsaw 24
Changsha 23
Chennai 23
Denver 23
Tashkent 23
Berlin 22
Brooklyn 22
Guangzhou 22
Jiaxing 22
Poplar 22
Vancouver 22
Atlanta 21
Baghdad 21
Haiphong 20
Kerken 20
Paris 20
Vienna 20
Amsterdam 19
Zhengzhou 19
Boston 18
Kumar 17
Ningbo 17
Phoenix 17
Saint Petersburg 17
San Francisco 17
Curitiba 16
Redondo Beach 16
Washington 16
Ankara 15
City of London 15
Toronto 15
Abidjan 14
Hangzhou 14
Totale 13.039
Salva come PNG Salva come JPEG
Nome #
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 333
Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients 313
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 297
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 281
A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers 280
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 274
Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success 274
Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitor 268
Clinical presentation and treatment of gastrointestinal stromal tumors. 265
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 259
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 259
Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale 255
Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy 255
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 253
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 252
Adherence, compliance and persistence to oral antineoplastic therapy: A review focused on chemotherapeutic and biologic agents 241
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 236
L'impiego del Tachosil in chirurgia epatica 227
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 221
Alexithymia and coping style in women going to visit in a breast cancer center. 219
Axillary Nodal Burden in Breast Cancer Patients With Pre-operative Fine Needle Aspiration-proven Positive Lymph Nodes Compared to Those With Positive Sentinel Nodes 219
Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study). 215
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 213
A Case of Follicular Tumor of Uncertain Malignant Potential (FT-UMP) with Glomeruloid Features Showing Capsular Mucinous Degeneration 213
A phase II study of capecitabine oxaliplatin chemotherapy in metastatic breast cancer patients pretreated with anthracyclines and taxanes 212
Mutational analysis of BRCA1 gene in sicilian patients at risk for inherited breast and/or ovarian cancer: experience of reference centre for the biomolecular characterization of neoplasms and genetic screening of hereditary tumors. 211
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer 209
Analysis of Ki-ras mutations in stage I rectal carcinomas and respective regional lymphonodes 208
Metastatic seeding of colon adenocarcinoma manifesting as synchronous breast and chest wall localization: report of a case. 207
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers 205
A.Mutational analysis of BRCA1 in sicilian patients at risk for inherited of reference center for the biomolecular characterizaztion of neoplasm and genetic screening of hereditary tumors 201
Evaluation of predictive factors for i-CLARAS (intraoperative complications in laparoscopic renal and adrenal surgery): a multicentre international retrospective cohort study 194
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients 191
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study. 188
Low dose oral chemotherapy for hormone refractory prostate carcinoma estramustine phosphate versus estramustine phosphate and etoposide. A Randomized phase II study of GSTU foundation 187
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials. 184
Effects of hypolipidemic and hypoglycemic agents on atherogenic small, dense LDL in Type 2 diabetes 184
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 182
Detection of free-circulating tumor DNA in plasma of patients with gastrointestinal cancer. 182
Mutational analysis of BRCA1 gene in sicilian patient at risk for inherited breast and/or ovarian cancer: experience of reference center the biomolecular characterization of neoplasm and genetic screening of hereditary tumors. 181
TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome 181
Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study 181
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer. Proceeding of ICACT Fifteenth International Congress on Anticancer Treatment February 9th 12th 2004, Paris accepted for oral presentation 180
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: The MITO-2 randomized phase III trial 180
Cardiotossicità e Cardioprotezione. 176
Gastric metastasis from breast cancer 175
TP53 mutations and S-Phase fraction are independent prognostic indicators in locally advanced laryngeal squamous cell carcinoma 172
A phase 2 study of Oxaliplatin ( O ) – Capecitabine( C ) chemotherapy in metastatic breast cancer ( MBC ) patients pretreated with Anthracyclines and taxanes VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 171
The prognostic role of TP53 mutations in advanced laryngeal squamous cell carcinoma (LSCC). 170
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study 170
Current Role of Intraoperative Frozen Section Examination of Sentinel Lymph Node in Early Breast Cancer 169
Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study 168
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer 165
TP53 mutations are not prognostic independent indicators in bladder cancer. 165
Epirubicina (EPI ) e Docetaxel (DOC ) come chemioterapia primaria ( C P ) nel trattamento del carcinoma mammario localmente avanzato ( CMLA ). VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 165
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study. 163
Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study 162
Alexithymia and copyng style in women going to visit in a breast cancer center 161
DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: Results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study 159
Metronomic Chemotherapy (mCHT) in HER2-ve Advanced Breast Cancer (ABC) Patients (PTS): When Care Objectives Meet Patients’ Need. Preliminary Results of the Victor-6 Study 157
Weekly Paclitaxel (T) and pegylated liposomal Doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 155
Studio di phase II: Docetaxel settimanale come seconda linea chemioterapia nel carcinoma prostatico avanzato. 154
The Use of Gemcitabine in heavily pretreted breast cancer patients 153
Pegylated Liposomal Doxorubicin and weekly paclitaxel as first line treatment in metastatic breast cancer 153
Hematologic toxicity of radium-223 in elderly patients with metastatic Castration Resistant Prostate Cancer: a real-life experience 152
Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA) 152
RUOLO DELL’ECOCOLOR DOPPLER TISSUTALE NELLA VALUTAZIONE DELLA CARDIOTOSSICITÀ DA CHEMIOTERAPICI 145
Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration refractory Metastatic Adenocarcinoma of the Prostate Resistant to Docetaxel 145
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer 145
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer 145
Effects of the number of removed lymph nodes on survival outcome in patients with sentinel node-negative breast cancer 145
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data 144
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis 142
Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma 141
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated? 141
GRUPPO ONCOLOGICO ITALIA MERIDIONALE. NOVEL ASSOCIATION WITH GEMCITABINE AND DOCETAXEL AS SALVAGE CHEMOTHERAPY IN METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH ANTHRACYCLINES: RESULT OF A NULTICENTER PHASE II STUDY 138
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 137
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9) 137
TP53 Mutation in exon 5 and S-Phase Fraction but not Mutations in Ras gene family and DNA-ploidy are Indipendent prognostic indicators in Laryngeal Squamous Cell Carcinoma 134
p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: A prospective study with a five-year follow-up 134
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 132
NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience 132
Comprehensive Axillary Management of Clinically Node-Positive (cN plus ) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy 130
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data 128
Novel association with gemcitabine and docetaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclines: results of a multicenter phase II study 127
Relationship between the thymidylate synthase, p53 levels with the treatment by Cyclophosphamide, Metotrexate, 5-Fluorouracil chemotherapy (CMF) versus Docetaxel (TXT) in the locally advanced carcinoma of breast. 126
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient 126
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 124
TP53 mutations are not prognostic indipendent indicators in bladder cancer 122
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 121
Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World 121
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 119
STUDIO DI FASE II: DOCETAXEL SETTIMANALE COME SECONDA LINEA CHEMIOTERAPICA NEL CARCINOMA PROSTATICO AVANZATO 119
Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma 119
A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer 116
Lapatinib activity in a patient with encephalic metastases from trastuzumab-resistant her-2 positive breast cancer 116
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review 113
A Practical Narrative Review on the Role of Magnesium in Cancer Therapy 113
Surviving Twenty Years to Bone and Liver Metastatic Breast Cancer: A Case Reported by Treating Oncologists and the Patient Herself 113
The HERBA trial: a retrospective study on patients (pts) with HER2-positive (HER2+ve) breast cancer (BC) and brain metastases (BMs) 111
Totale 17.958
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.018
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021324 0 0 0 0 0 0 0 0 0 0 158 166
2021/20221.307 81 252 26 76 69 48 84 67 147 156 81 220
2022/20231.607 166 310 29 155 189 243 105 110 164 8 72 56
2023/2024987 41 127 80 72 62 138 181 55 25 19 58 129
2024/20252.704 71 198 249 205 119 80 191 189 188 312 293 609
2025/20269.295 677 416 632 731 980 1.284 1.229 1.015 783 1.077 471 0
Totale 22.044